Neurologists, Cardiologists and GPs working together
... GP referred patients “at-risk” of stroke who, in the opinion of the GP, would benefit from combined cardiac and neurological assessments. Agreement by neurologist and cardiologist that “urgent” referrals can be seen through this clinic. Patients see neurologist and cardiologist on same day. Investig ...
... GP referred patients “at-risk” of stroke who, in the opinion of the GP, would benefit from combined cardiac and neurological assessments. Agreement by neurologist and cardiologist that “urgent” referrals can be seen through this clinic. Patients see neurologist and cardiologist on same day. Investig ...
Full Text:PDF - The Turkish Journal of Pediatrics
... 17 years). Seventy-six children (51%) were symptomatic. Most of the patients had unifocal PVC, whereas 5 (3.1%) of them had multifocal PVCs. The patients were evaluated by repeated Holter recordings and exercise test. In the first Holter monitoring recordings, PVCs were in the form of isolated PVC i ...
... 17 years). Seventy-six children (51%) were symptomatic. Most of the patients had unifocal PVC, whereas 5 (3.1%) of them had multifocal PVCs. The patients were evaluated by repeated Holter recordings and exercise test. In the first Holter monitoring recordings, PVCs were in the form of isolated PVC i ...
Ventricular Septal Defect
... (iNO, IV pulmonary vasodilators) (See Peds/Neo Problem Guidelines for Pulmonary Hypertension) o Inotropic support Majority with minimal inotropic support Repair of VSD with complex lesions or PAH May also consider pulmonary vasodilators o Monitor for the following complications: Arrhythmias ...
... (iNO, IV pulmonary vasodilators) (See Peds/Neo Problem Guidelines for Pulmonary Hypertension) o Inotropic support Majority with minimal inotropic support Repair of VSD with complex lesions or PAH May also consider pulmonary vasodilators o Monitor for the following complications: Arrhythmias ...
Neural Networks in ECG classification
... has started since 1943 by McCulloch and Pitts. Pattern recognition problem was introduced by Rosenblatt (1958) ...
... has started since 1943 by McCulloch and Pitts. Pattern recognition problem was introduced by Rosenblatt (1958) ...
Document
... fist sound caused by vibrations set up by the sudden closure of the mitral and tricuspid valves at the start of ventricula systole ...
... fist sound caused by vibrations set up by the sudden closure of the mitral and tricuspid valves at the start of ventricula systole ...
Heart failure from heart muscle disease in childhood: a 5–10 year
... compared with cardiomyopathy registry series, the findings are an important addition to the current literature and will hopefully help guide clinicians and families in making decisions about treatment options at each stage of the patient journey. ...
... compared with cardiomyopathy registry series, the findings are an important addition to the current literature and will hopefully help guide clinicians and families in making decisions about treatment options at each stage of the patient journey. ...
3/09 LV Systolic Function
... Ping Sun J et al. J Am Soc Echocardiogr 2004;17:132-8. R Senior et al. European Heart Journal (1994) 15, 1235-1239 Bhatia VK, Senior R. Contrast Echocardiography: Evidence for Clinical Use. Journal of the American Society of Echocardiography May 2008. 409-416. Hoffmann R et al. Analysis of Regional ...
... Ping Sun J et al. J Am Soc Echocardiogr 2004;17:132-8. R Senior et al. European Heart Journal (1994) 15, 1235-1239 Bhatia VK, Senior R. Contrast Echocardiography: Evidence for Clinical Use. Journal of the American Society of Echocardiography May 2008. 409-416. Hoffmann R et al. Analysis of Regional ...
Perioperative Major Aortopulmonary Collateral Arteries
... Major aortopulmonary collateral arteries (MAPCAs) are blood vessels that bring systemic blood flow to the pulmonary arteries. They develop in response to decreased pulmonary blood flow and cyanosis. MAPCAs may be an additional source of blood supply to the lungs along with the native pulmonary arter ...
... Major aortopulmonary collateral arteries (MAPCAs) are blood vessels that bring systemic blood flow to the pulmonary arteries. They develop in response to decreased pulmonary blood flow and cyanosis. MAPCAs may be an additional source of blood supply to the lungs along with the native pulmonary arter ...
Azimilide for the Treatment of Atrial Fibrillation, Atrial
... resting heart rate below 50 beats per minute; history of Mobitz type II or complete heart block; current use of class I or class III antiarrhythmic drugs (and no amiodarone for 1 month); unresolved organ toxicity due to amiodarone; use of other agents that prolong QTc within five half-lives of the a ...
... resting heart rate below 50 beats per minute; history of Mobitz type II or complete heart block; current use of class I or class III antiarrhythmic drugs (and no amiodarone for 1 month); unresolved organ toxicity due to amiodarone; use of other agents that prolong QTc within five half-lives of the a ...
Aortic Regurgitation - Cormedicalgroup.com
... appear, that is, an irregular heart rate, which occurs when the heart muscle weakens on account of the chronic leakage from the aortic valve. ...
... appear, that is, an irregular heart rate, which occurs when the heart muscle weakens on account of the chronic leakage from the aortic valve. ...
Canine Heart Disease
... There are many medications that can be used in the treatment of heart disease and the individual treatment plan is dependent on the clinical signs, and type and severity of heart disease present. A combination of medications is typically prescribed: ACE inhibitors may be used to reduce the risk ...
... There are many medications that can be used in the treatment of heart disease and the individual treatment plan is dependent on the clinical signs, and type and severity of heart disease present. A combination of medications is typically prescribed: ACE inhibitors may be used to reduce the risk ...
PDF - Journals
... reduced aortic distensibility plays an important role in exercise intolerance of this group of patients.1-5 Aortic distensibility can be reliably estimated by aortic pulsewave velocity (PWV). PWV is the gold standard method for measuring arterial stiffness.6,7 Several studies have shown that the PWV ...
... reduced aortic distensibility plays an important role in exercise intolerance of this group of patients.1-5 Aortic distensibility can be reliably estimated by aortic pulsewave velocity (PWV). PWV is the gold standard method for measuring arterial stiffness.6,7 Several studies have shown that the PWV ...
Common RyR2 variants associate with ventricular arrhythmias and
... York Heart Association) functional class II–IV despite optimized medical therapy; and LV (left ventricular) systolic dysfunction with an LVEF (LV ejection fraction) 50 % in ischaemic heart disease and 45 % in dilated cardiomyopathy. HF severity was defined as mild (40 %< LVEF 50 %), moderate ( ...
... York Heart Association) functional class II–IV despite optimized medical therapy; and LV (left ventricular) systolic dysfunction with an LVEF (LV ejection fraction) 50 % in ischaemic heart disease and 45 % in dilated cardiomyopathy. HF severity was defined as mild (40 %< LVEF 50 %), moderate ( ...
Heart Failure Functional Class Associated with Depression Severity
... co-morbidities were assessed for all patients. In addition, laboratory, echocardiographic and electrocardiographic (ECG) findings were recorded (Tables 1 and 2). The Beck Depression Inventory (BDI) and the Beck Anxiety Inventory (BAI) were used to measure the frequency and severity of patient depres ...
... co-morbidities were assessed for all patients. In addition, laboratory, echocardiographic and electrocardiographic (ECG) findings were recorded (Tables 1 and 2). The Beck Depression Inventory (BDI) and the Beck Anxiety Inventory (BAI) were used to measure the frequency and severity of patient depres ...
Acute and Chronic Heart Failure Therapies in Patients With
... heart failure medications is conflicting. Furthermore, the use of aspirin or antiplatelets is controversial as some studies have not shown any benefit although one trial demonstrated a reduction in major adverse cardiovascular events. At present there are no randomized trials to assess outcomes in p ...
... heart failure medications is conflicting. Furthermore, the use of aspirin or antiplatelets is controversial as some studies have not shown any benefit although one trial demonstrated a reduction in major adverse cardiovascular events. At present there are no randomized trials to assess outcomes in p ...
JBHA 9 Chapter 30 – Human Body Systems LAB – Chicken Heart
... atrium and ventricle, which receives (oxygenated / deoxygenated) blood from the body and sends it to ______________ and a left atrium and ventricle, which receives (oxygenated / deoxygenated) blood from the lungs and sends it to _______________. Birds have a much higher metabolic rate than humans. T ...
... atrium and ventricle, which receives (oxygenated / deoxygenated) blood from the body and sends it to ______________ and a left atrium and ventricle, which receives (oxygenated / deoxygenated) blood from the lungs and sends it to _______________. Birds have a much higher metabolic rate than humans. T ...
CV - Imperial College London
... 1. OCEAC Prize for Biology – ranked first across three exam boards for best overall performance nationally and internationally in A-Level Biology. 1998 2. OCEAC Certificate of Excellence for Chemistry – top 5 in A-Level Chemistry nationally and internationally across three exam boards 1998 3. The In ...
... 1. OCEAC Prize for Biology – ranked first across three exam boards for best overall performance nationally and internationally in A-Level Biology. 1998 2. OCEAC Certificate of Excellence for Chemistry – top 5 in A-Level Chemistry nationally and internationally across three exam boards 1998 3. The In ...
Heart rate as a treatable cardiovascular risk factor
... annualized mortality rate and HR in these studies, and a strong correlation between change in HR and change in left ventricular ejection fraction was also observed.26 Beta-blockers are a cornerstone of HF treatment, but their efficacy in elderly patients is less known as such patients are often excl ...
... annualized mortality rate and HR in these studies, and a strong correlation between change in HR and change in left ventricular ejection fraction was also observed.26 Beta-blockers are a cornerstone of HF treatment, but their efficacy in elderly patients is less known as such patients are often excl ...
Arrhythmogenic Right Ventricular Dysplasia Overview
... nonsustained VT (sotolol, flecainide, tikosyn, amiodarone) Consider catheter ablation if AA drugs do not work or have side effects. ...
... nonsustained VT (sotolol, flecainide, tikosyn, amiodarone) Consider catheter ablation if AA drugs do not work or have side effects. ...
Right ventricular failure in congenital heart disease
... and atrioventricular block may have profound hemodynamic effects18). In patients with RV dysfunction and valvular heart disease or CHD, corrective surgery or percutaneous intervention should be considered in suitable candidates18,39,40). Clinically, the assessment of optimal preload in RV failure r ...
... and atrioventricular block may have profound hemodynamic effects18). In patients with RV dysfunction and valvular heart disease or CHD, corrective surgery or percutaneous intervention should be considered in suitable candidates18,39,40). Clinically, the assessment of optimal preload in RV failure r ...
Activation of cytokines as a mechanism of disease progression in
... these features. At three months, 67% of the reactive patients who received prednisone had improvement in LV function, as compared with 28% of the reactive controls (p=0.004). In contrast, non-reactive patients did not improve with prednisone. Although specific cytokine levels were not measured in th ...
... these features. At three months, 67% of the reactive patients who received prednisone had improvement in LV function, as compared with 28% of the reactive controls (p=0.004). In contrast, non-reactive patients did not improve with prednisone. Although specific cytokine levels were not measured in th ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.